EUVIMEDOpdag EUVIMED
Crossref

Confounding Factors in Targeted Degradation of Short-Lived Proteins

Vesna Vetma iD, Laura Casares Perez, Ján Eliaš, Andrea Stingu, Anju Kombara, Teresa Gmaschitz, Nina Braun iD, Tuncay Ciftci, Georg Dahmann, Emelyne Diers, Thomas Gerstberger iD, Peter Greb iD and 14 more

ACS Chemical Biology · 2024-07-19 · 19 (7) · 1484-1494

DOI: 10.1021/acschembio.4c00152 ↗

At a glance

Journal article in ACS Chemical Biology, published online on 2024-07-03. Written by Vesna Vetma and 25 co-authors. Institution: Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, DD1 5JJ Dundee, Scotland, U.K. Major MEDLINE topics: Proteolysis. Cited 49 times so far (Crossref); 36 references.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Targeted protein degradation has recently emerged as a novel option in drug discovery. Natural protein half-life is expected to affect the efficacy of degrading agents, but to what extent it influences target protein degradation has not been systematically explored. Using simple mathematical modeling of protein degradation, we find that the natural half-life of a target protein has a dramatic effect on the level of protein degradation induced by a degrader agent which can pose significant hurdles to screening efforts. Moreover, we show that upon screening for degraders of short-lived proteins, agents that stall protein synthesis, such as GSPT1 degraders and generally cytotoxic compounds, deceptively appear as protein-degrading agents. This is exemplified by the disappearance of short-lived proteins such as MCL1 and MDM2 upon GSPT1 degradation and upon treatment with cytotoxic agents such as doxorubicin. These findings have implications for target selection as well as for the type of control experiments required to conclude that a novel agent works as a bona fide targeted protein degrader.

Subjects

MeSH terms (MEDLINE)

ProteolysisHumansProto-Oncogene Proteins c-mdm2Half-LifeDoxorubicinMyeloid Cell Leukemia Sequence 1 ProteinProteins

Substances

Proto-Oncogene Proteins c-mdm2DoxorubicinMyeloid Cell Leukemia Sequence 1 ProteinProteins

Authors and institutions

  • Centre for Targeted Protein Degradation, School of Life Sciences, University of Dundee, 1 James Lindsay Place, DD1 5JJ Dundee, Scotland, U.K.
  • Division of Biological Chemistry and Drug Discovery, School of Life Sciences, James Black Centre, University of Dundee, Dow Street, DD1 5EH Dundee, Scotland, U.K.
  • Boehringer Ingelheim RCV GmbH & Co KG, 1221 Vienna, Austria.

ORCID profiles: Vesna Vetma, Nina Braun, Thomas Gerstberger, Peter Greb, Nicole Trainor, Harald Weinstabl, Yvonne Westermaier, Alessio Ciulli, Manfred Koegl

Cite

APA

Vetma, V., Perez, L. C., Eliaš, J., Stingu, A., Kombara, A., Gmaschitz, T., Braun, N., Ciftci, T., Dahmann, G., Diers, E., Gerstberger, T., Greb, P., Kidd, G., Kofink, C., Puoti, I., Spiteri, V., Trainor, N., Weinstabl, H., Westermaier, Y., …, & Koegl, M. (2024). Confounding Factors in Targeted Degradation of Short-Lived Proteins. ACS Chemical Biology, 19(7), 1484-1494. https://doi.org/10.1021/acschembio.4c00152

Vancouver

Vetma V, Perez LC, Eliaš J, Stingu A, Kombara A, Gmaschitz T, et al. Confounding Factors in Targeted Degradation of Short-Lived Proteins. ACS Chemical Biology. 2024;19(7):1484-1494. doi:10.1021/acschembio.4c00152

BibTeX
@article{Vetma2024,
  author = {Vetma, Vesna and Perez, Laura Casares and Eliaš, Ján and Stingu, Andrea and Kombara, Anju and Gmaschitz, Teresa and Braun, Nina and Ciftci, Tuncay and Dahmann, Georg and Diers, Emelyne and Gerstberger, Thomas and Greb, Peter and Kidd, Giorgia and Kofink, Christiane and Puoti, Ilaria and Spiteri, Valentina and Trainor, Nicole and Weinstabl, Harald and Westermaier, Yvonne and Whitworth, Claire and Ciulli, Alessio and Farnaby, William and McAulay, Kirsten and Frost, Aileen B and Chessum, Nicola and Koegl, Manfred},
  title = {Confounding Factors in Targeted Degradation of Short-Lived Proteins},
  journal = {ACS Chemical Biology},
  year = {2024},
  volume = {19},
  number = {7},
  pages = {1484--1494},
  doi = {10.1021/acschembio.4c00152}
}
Start for free →